Test Longevity Interventions In Your Own Cells Before You Try Them
Mike Lustgarten explores using cellular testing to screen longevity interventions personally before committing to them.
59 articles
Mike Lustgarten explores using cellular testing to screen longevity interventions personally before committing to them.
From CAR T-cell senolytics to AI-designed reprogramming factors, 2025 delivered landmark advances in aging science.
A new minimal model from physicists suggests aging is governed by just 3 variables β and most anti-aging drugs only address the first level.
A natural flavonoid found in fruits clears senescent cells and restores artery function damaged by doxorubicin chemotherapy in mice.
The European Innovation Council is offering up to β¬4M per project to turn aging research into real therapies. Deadline: October 2026.
A new review reframes epigenetic clocks as direct readouts of epigenetic drift, deepening our understanding of biological aging measurement.
New research reveals how aging transforms protective immune cells into drivers of inflammation, senescence, and tissue damage.
A new Nature Communications study identifies NRF1 as a master driver of inflammaging via the TBK1/IRF3 innate immune axis.
A new review maps the molecular mechanisms behind liver aging and evaluates dietary, drug, and gene-editing interventions to slow decline.
A landmark 2025 review maps every mechanism behind arterial stiffnessβand charts a clear path toward prevention and therapy.
A landmark review synthesizes 12 hallmarks of aging, emerging gerotherapeutics, and a new three-tier clinical care model to shift medicine from disease treatment to aging prevention.
A comprehensive review reveals metformin's polypharmacological mechanismsβfrom AMPK activation to gut microbiome remodelingβthat may delay aging and enhance cancer immunotherapy.